This report contains market size and forecasts of Acute Lung Injury in Global, including the following market information:
Global Acute Lung Injury Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Acute Lung Injury market was valued at 531.6 million in 2020 and is projected to reach US$ 637.6 million by 2027, at a CAGR of 4.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Lung Injury companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Lung Injury Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Acute Lung Injury Market Segment Percentages, By Type, 2020 (%)
Pharmacotherapy
Mechanical Ventilation
Adjunctive Procedures
Fluid Management
Others
China Acute Lung Injury Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Acute Lung Injury Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others
Global Acute Lung Injury Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Acute Lung Injury Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Acute Lung Injury Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Acute Lung Injury Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Altor BioScience
FirstString Research
GlaxoSmithKline
Forschung und Entwicklung
Commence Bio
CompleGen
Histocell S.L.
Stemedica Cell Technologies
Windtree Therapeutics
S-Evans Biosciences
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Acute Lung Injury Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Lung Injury Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Lung Injury Overall Market Size
2.1 Global Acute Lung Injury Market Size: 2021 VS 2027
2.2 Global Acute Lung Injury Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Lung Injury Players in Global Market
3.2 Top Global Acute Lung Injury Companies Ranked by Revenue
3.3 Global Acute Lung Injury Revenue by Companies
3.4 Top 3 and Top 5 Acute Lung Injury Companies in Global Market, by Revenue in 2020
3.5 Global Companies Acute Lung Injury Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Lung Injury Players in Global Market
3.6.1 List of Global Tier 1 Acute Lung Injury Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Lung Injury Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Lung Injury Market Size Markets, 2021 & 2027
4.1.2 Pharmacotherapy
4.1.3 Mechanical Ventilation
4.1.4 Adjunctive Procedures
4.1.5 Fluid Management
4.1.6 Others
4.2 By Type - Global Acute Lung Injury Revenue & Forecasts
4.2.1 By Type - Global Acute Lung Injury Revenue, 2016-2021
4.2.2 By Type - Global Acute Lung Injury Revenue, 2022-2027
4.2.3 By Type - Global Acute Lung Injury Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Lung Injury Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Acute Lung Injury Revenue & Forecasts
5.2.1 By Application - Global Acute Lung Injury Revenue, 2016-2021
5.2.2 By Application - Global Acute Lung Injury Revenue, 2022-2027
5.2.3 By Application - Global Acute Lung Injury Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Acute Lung Injury Market Size, 2021 & 2027
6.2 By Region - Global Acute Lung Injury Revenue & Forecasts
6.2.1 By Region - Global Acute Lung Injury Revenue, 2016-2021
6.2.2 By Region - Global Acute Lung Injury Revenue, 2022-2027
6.2.3 By Region - Global Acute Lung Injury Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Acute Lung Injury Revenue, 2016-2027
6.3.2 US Acute Lung Injury Market Size, 2016-2027
6.3.3 Canada Acute Lung Injury Market Size, 2016-2027
6.3.4 Mexico Acute Lung Injury Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Acute Lung Injury Revenue, 2016-2027
6.4.2 Germany Acute Lung Injury Market Size, 2016-2027
6.4.3 France Acute Lung Injury Market Size, 2016-2027
6.4.4 U.K. Acute Lung Injury Market Size, 2016-2027
6.4.5 Italy Acute Lung Injury Market Size, 2016-2027
6.4.6 Russia Acute Lung Injury Market Size, 2016-2027
6.4.7 Nordic Countries Acute Lung Injury Market Size, 2016-2027
6.4.8 Benelux Acute Lung Injury Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Acute Lung Injury Revenue, 2016-2027
6.5.2 China Acute Lung Injury Market Size, 2016-2027
6.5.3 Japan Acute Lung Injury Market Size, 2016-2027
6.5.4 South Korea Acute Lung Injury Market Size, 2016-2027
6.5.5 Southeast Asia Acute Lung Injury Market Size, 2016-2027
6.5.6 India Acute Lung Injury Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Acute Lung Injury Revenue, 2016-2027
6.6.2 Brazil Acute Lung Injury Market Size, 2016-2027
6.6.3 Argentina Acute Lung Injury Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Lung Injury Revenue, 2016-2027
6.7.2 Turkey Acute Lung Injury Market Size, 2016-2027
6.7.3 Israel Acute Lung Injury Market Size, 2016-2027
6.7.4 Saudi Arabia Acute Lung Injury Market Size, 2016-2027
6.7.5 UAE Acute Lung Injury Market Size, 2016-2027
7 Players Profiles
7.1 Altor BioScience
7.1.1 Altor BioScience Corporate Summary
7.1.2 Altor BioScience Business Overview
7.1.3 Altor BioScience Acute Lung Injury Major Product Offerings
7.1.4 Altor BioScience Acute Lung Injury Revenue in Global (2016-2021)
7.1.5 Altor BioScience Key News
7.2 FirstString Research
7.2.1 FirstString Research Corporate Summary
7.2.2 FirstString Research Business Overview
7.2.3 FirstString Research Acute Lung Injury Major Product Offerings
7.2.4 FirstString Research Acute Lung Injury Revenue in Global (2016-2021)
7.2.5 FirstString Research Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Acute Lung Injury Major Product Offerings
7.3.4 GlaxoSmithKline Acute Lung Injury Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Forschung und Entwicklung
7.4.1 Forschung und Entwicklung Corporate Summary
7.4.2 Forschung und Entwicklung Business Overview
7.4.3 Forschung und Entwicklung Acute Lung Injury Major Product Offerings
7.4.4 Forschung und Entwicklung Acute Lung Injury Revenue in Global (2016-2021)
7.4.5 Forschung und Entwicklung Key News
7.5 Commence Bio
7.5.1 Commence Bio Corporate Summary
7.5.2 Commence Bio Business Overview
7.5.3 Commence Bio Acute Lung Injury Major Product Offerings
7.5.4 Commence Bio Acute Lung Injury Revenue in Global (2016-2021)
7.5.5 Commence Bio Key News
7.6 CompleGen
7.6.1 CompleGen Corporate Summary
7.6.2 CompleGen Business Overview
7.6.3 CompleGen Acute Lung Injury Major Product Offerings
7.6.4 CompleGen Acute Lung Injury Revenue in Global (2016-2021)
7.6.5 CompleGen Key News
7.7 Histocell S.L.
7.7.1 Histocell S.L. Corporate Summary
7.7.2 Histocell S.L. Business Overview
7.7.3 Histocell S.L. Acute Lung Injury Major Product Offerings
7.4.4 Histocell S.L. Acute Lung Injury Revenue in Global (2016-2021)
7.7.5 Histocell S.L. Key News
7.8 Stemedica Cell Technologies
7.8.1 Stemedica Cell Technologies Corporate Summary
7.8.2 Stemedica Cell Technologies Business Overview
7.8.3 Stemedica Cell Technologies Acute Lung Injury Major Product Offerings
7.8.4 Stemedica Cell Technologies Acute Lung Injury Revenue in Global (2016-2021)
7.8.5 Stemedica Cell Technologies Key News
7.9 Windtree Therapeutics
7.9.1 Windtree Therapeutics Corporate Summary
7.9.2 Windtree Therapeutics Business Overview
7.9.3 Windtree Therapeutics Acute Lung Injury Major Product Offerings
7.9.4 Windtree Therapeutics Acute Lung Injury Revenue in Global (2016-2021)
7.9.5 Windtree Therapeutics Key News
7.10 S-Evans Biosciences
7.10.1 S-Evans Biosciences Corporate Summary
7.10.2 S-Evans Biosciences Business Overview
7.10.3 S-Evans Biosciences Acute Lung Injury Major Product Offerings
7.10.4 S-Evans Biosciences Acute Lung Injury Revenue in Global (2016-2021)
7.10.5 S-Evans Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acute Lung Injury Market Opportunities & Trends in Global Market
Table 2. Acute Lung Injury Market Drivers in Global Market
Table 3. Acute Lung Injury Market Restraints in Global Market
Table 4. Key Players of Acute Lung Injury in Global Market
Table 5. Top Acute Lung Injury Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Acute Lung Injury Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Acute Lung Injury Revenue Share by Companies, 2016-2021
Table 8. Global Companies Acute Lung Injury Product Type
Table 9. List of Global Tier 1 Acute Lung Injury Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Lung Injury Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type